DE2108366A1 - Pharmakologisch wirksamer Stoff und seine Isolierung aus Cabucala madagascariensis - Google Patents
Pharmakologisch wirksamer Stoff und seine Isolierung aus Cabucala madagascariensisInfo
- Publication number
- DE2108366A1 DE2108366A1 DE19712108366 DE2108366A DE2108366A1 DE 2108366 A1 DE2108366 A1 DE 2108366A1 DE 19712108366 DE19712108366 DE 19712108366 DE 2108366 A DE2108366 A DE 2108366A DE 2108366 A1 DE2108366 A1 DE 2108366A1
- Authority
- DE
- Germany
- Prior art keywords
- cabucala
- active ingredient
- madagascariensis
- salts
- physiologically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241001270491 Petchia madagascariensis Species 0.000 title claims description 10
- 239000013543 active substance Substances 0.000 title claims description 7
- 238000002955 isolation Methods 0.000 title description 2
- 239000004480 active ingredient Substances 0.000 claims description 20
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 18
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 239000006286 aqueous extract Substances 0.000 claims description 8
- 239000000243 solution Substances 0.000 claims description 8
- 230000003276 anti-hypertensive effect Effects 0.000 claims description 7
- 238000000605 extraction Methods 0.000 claims description 7
- 150000003839 salts Chemical class 0.000 claims description 7
- 239000002253 acid Substances 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- 239000007864 aqueous solution Substances 0.000 claims description 5
- 125000004432 carbon atom Chemical group C* 0.000 claims description 5
- 150000007513 acids Chemical class 0.000 claims description 4
- -1 aliphatic halogenated hydrocarbons Chemical class 0.000 claims description 4
- 239000003814 drug Substances 0.000 claims description 4
- 229940079593 drug Drugs 0.000 claims description 4
- 241000196324 Embryophyta Species 0.000 claims description 3
- 150000002148 esters Chemical class 0.000 claims description 3
- 125000005843 halogen group Chemical group 0.000 claims description 3
- 239000000155 melt Substances 0.000 claims description 3
- UOCLXMDMGBRAIB-UHFFFAOYSA-N 1,1,1-trichloroethane Chemical compound CC(Cl)(Cl)Cl UOCLXMDMGBRAIB-UHFFFAOYSA-N 0.000 claims description 2
- 208000024172 Cardiovascular disease Diseases 0.000 claims description 2
- XSTXAVWGXDQKEL-UHFFFAOYSA-N Trichloroethylene Chemical group ClC=C(Cl)Cl XSTXAVWGXDQKEL-UHFFFAOYSA-N 0.000 claims description 2
- 238000010521 absorption reaction Methods 0.000 claims description 2
- 150000001733 carboxylic acid esters Chemical class 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 229930195733 hydrocarbon Natural products 0.000 claims description 2
- 150000002430 hydrocarbons Chemical class 0.000 claims description 2
- 238000001819 mass spectrum Methods 0.000 claims description 2
- 238000002211 ultraviolet spectrum Methods 0.000 claims description 2
- TZIHFWKZFHZASV-UHFFFAOYSA-N methyl formate Chemical compound COC=O TZIHFWKZFHZASV-UHFFFAOYSA-N 0.000 claims 2
- 239000004215 Carbon black (E152) Substances 0.000 claims 1
- 101150052863 THY1 gene Proteins 0.000 claims 1
- 239000004744 fabric Substances 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- 241000915830 Cabucala Species 0.000 description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 230000037396 body weight Effects 0.000 description 4
- 150000008282 halocarbons Chemical class 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 3
- 229930182558 Sterol Natural products 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 238000004108 freeze drying Methods 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 150000003432 sterols Chemical class 0.000 description 3
- 235000003702 sterols Nutrition 0.000 description 3
- 239000001993 wax Substances 0.000 description 3
- 241000282472 Canis lupus familiaris Species 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Chemical compound OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 230000001476 alcoholic effect Effects 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000003480 eluent Substances 0.000 description 2
- WBJINCZRORDGAQ-UHFFFAOYSA-N formic acid ethyl ester Natural products CCOC=O WBJINCZRORDGAQ-UHFFFAOYSA-N 0.000 description 2
- 238000004816 paper chromatography Methods 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 235000019871 vegetable fat Nutrition 0.000 description 2
- 230000002861 ventricular Effects 0.000 description 2
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 241000208327 Apocynaceae Species 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 206010047141 Vasodilatation Diseases 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- 239000003929 acidic solution Substances 0.000 description 1
- 239000012675 alcoholic extract Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 229910052787 antimony Inorganic materials 0.000 description 1
- WATWJIUSRGPENY-UHFFFAOYSA-N antimony atom Chemical compound [Sb] WATWJIUSRGPENY-UHFFFAOYSA-N 0.000 description 1
- 230000035565 breathing frequency Effects 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 235000012730 carminic acid Nutrition 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000001055 chewing effect Effects 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 210000003748 coronary sinus Anatomy 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 229940075930 picrate Drugs 0.000 description 1
- OXNIZHLAWKMVMX-UHFFFAOYSA-M picrate anion Chemical compound [O-]C1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-M 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 210000002254 renal artery Anatomy 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/24—Apocynaceae (Dogbane family), e.g. plumeria or periwinkle
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
- Compounds Of Unknown Constitution (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (16)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19712108366 DE2108366A1 (de) | 1971-02-22 | 1971-02-22 | Pharmakologisch wirksamer Stoff und seine Isolierung aus Cabucala madagascariensis |
| RO69779A RO61141A (OSRAM) | 1971-02-22 | 1972-02-16 | |
| NL7202100A NL7202100A (OSRAM) | 1971-02-22 | 1972-02-17 | |
| GB762572A GB1382073A (en) | 1971-02-22 | 1972-02-18 | Pharmacologically effective substance and its isolation from cabucala madagascariensis |
| IL38800A IL38800A (en) | 1971-02-22 | 1972-02-20 | Pharmacologically effective substance and its isolation from cabucala madagascariensis |
| ZA721130A ZA721130B (en) | 1971-02-22 | 1972-02-21 | Pharmacologically effective substance and its isolation from cabucala madagascariensis |
| DK79972AA DK131272B (da) | 1971-02-22 | 1972-02-21 | Fremgangsmåde til isolering af et farmakologisk virksomt stof fra Cabucala madagascariensis. |
| OA54497A OA03966A (fr) | 1971-02-22 | 1972-02-21 | Procédé d'isolement d'une nouvelle substance à partir de cabucala madagascariensis. |
| CA135,233A CA976542A (en) | 1971-02-22 | 1972-02-21 | Pharmacologically effective substance and its isolation from cabucala madagascariensis |
| FR7205738A FR2126244B1 (OSRAM) | 1971-02-22 | 1972-02-21 | |
| AU39172/72A AU461396B2 (en) | 1971-02-22 | 1972-02-21 | Pharmacologically effective substance isolated from cabucala madagaascariensis |
| AT139872A AT319465B (de) | 1971-02-22 | 1972-02-21 | Verfahren zur Isolierung eines neuen pharmakologisch wirksamen Stoffes aus Cabucala madagascariensis |
| US00227919A US3773931A (en) | 1971-02-22 | 1972-02-22 | Pharmacologically effective substance isolated from cabucala madagascariensis |
| SE7202121A SE390107B (sv) | 1971-02-22 | 1972-02-22 | Forfarande for isolering av ett farmakologiskt verksamt emne fran cabucala madagascariensis |
| BE779653A BE779653A (fr) | 1971-02-22 | 1972-02-22 | Substance a effet pharmacologique et son isolement de cabucala madagascariensis |
| HUHO1457A HU163554B (OSRAM) | 1971-02-22 | 1972-02-22 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19712108366 DE2108366A1 (de) | 1971-02-22 | 1971-02-22 | Pharmakologisch wirksamer Stoff und seine Isolierung aus Cabucala madagascariensis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE2108366A1 true DE2108366A1 (de) | 1972-09-07 |
Family
ID=5799473
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19712108366 Pending DE2108366A1 (de) | 1971-02-22 | 1971-02-22 | Pharmakologisch wirksamer Stoff und seine Isolierung aus Cabucala madagascariensis |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US3773931A (OSRAM) |
| AT (1) | AT319465B (OSRAM) |
| AU (1) | AU461396B2 (OSRAM) |
| BE (1) | BE779653A (OSRAM) |
| CA (1) | CA976542A (OSRAM) |
| DE (1) | DE2108366A1 (OSRAM) |
| DK (1) | DK131272B (OSRAM) |
| FR (1) | FR2126244B1 (OSRAM) |
| GB (1) | GB1382073A (OSRAM) |
| HU (1) | HU163554B (OSRAM) |
| IL (1) | IL38800A (OSRAM) |
| NL (1) | NL7202100A (OSRAM) |
| OA (1) | OA03966A (OSRAM) |
| RO (1) | RO61141A (OSRAM) |
| SE (1) | SE390107B (OSRAM) |
| ZA (1) | ZA721130B (OSRAM) |
-
1971
- 1971-02-22 DE DE19712108366 patent/DE2108366A1/de active Pending
-
1972
- 1972-02-16 RO RO69779A patent/RO61141A/ro unknown
- 1972-02-17 NL NL7202100A patent/NL7202100A/xx unknown
- 1972-02-18 GB GB762572A patent/GB1382073A/en not_active Expired
- 1972-02-20 IL IL38800A patent/IL38800A/xx unknown
- 1972-02-21 AT AT139872A patent/AT319465B/de not_active IP Right Cessation
- 1972-02-21 ZA ZA721130A patent/ZA721130B/xx unknown
- 1972-02-21 FR FR7205738A patent/FR2126244B1/fr not_active Expired
- 1972-02-21 DK DK79972AA patent/DK131272B/da unknown
- 1972-02-21 AU AU39172/72A patent/AU461396B2/en not_active Expired
- 1972-02-21 OA OA54497A patent/OA03966A/xx unknown
- 1972-02-21 CA CA135,233A patent/CA976542A/en not_active Expired
- 1972-02-22 BE BE779653A patent/BE779653A/xx unknown
- 1972-02-22 SE SE7202121A patent/SE390107B/xx unknown
- 1972-02-22 US US00227919A patent/US3773931A/en not_active Expired - Lifetime
- 1972-02-22 HU HUHO1457A patent/HU163554B/hu unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL38800A0 (en) | 1972-04-27 |
| HU163554B (OSRAM) | 1973-09-27 |
| ZA721130B (en) | 1972-11-29 |
| GB1382073A (en) | 1975-01-29 |
| CA976542A (en) | 1975-10-21 |
| NL7202100A (OSRAM) | 1972-08-24 |
| BE779653A (fr) | 1972-08-22 |
| OA03966A (fr) | 1979-08-31 |
| FR2126244B1 (OSRAM) | 1975-03-14 |
| DK131272B (da) | 1975-06-23 |
| AT319465B (de) | 1974-12-27 |
| AU461396B2 (en) | 1975-05-08 |
| FR2126244A1 (OSRAM) | 1972-10-06 |
| SE390107B (sv) | 1976-12-06 |
| RO61141A (OSRAM) | 1977-02-15 |
| IL38800A (en) | 1974-12-31 |
| AU3917272A (en) | 1973-08-23 |
| DK131272C (OSRAM) | 1975-11-17 |
| US3773931A (en) | 1973-11-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2557784C2 (de) | Forskolin, Verfahren zu dessen Gewinnung und diese Verbindung enthaltende pharmazeutische Präparate | |
| DE2524355A1 (de) | Physiologisch aktive verbindungen und verfahren zu ihrer herstellung | |
| DE2640275A1 (de) | Pharmakologisch wirksame substanz aus labiaten | |
| EP0192056B1 (de) | Verfahren zur Herstellung von Labdan-Derivaten und ihre Verwendung als Arzneimittel | |
| DE3132655A1 (de) | Heisswasserextrakt der borke des paternosterbaumes | |
| CH644864A5 (de) | Psoralenderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate. | |
| DE2347576A1 (de) | Anti-leukaemische substanz sowie verfahren zur herstellung einer solchen substanz | |
| DE2124023C3 (de) | Verfahren zur selektiven Gewinnung von Vinblastin, Vinleurosin und Vincristin oder von deren Sulfaten | |
| DE3026654A1 (de) | Halogenvincamonderivate, verfahren zu deren herstellung und diese enthaltende arzneimittel | |
| DE2108366A1 (de) | Pharmakologisch wirksamer Stoff und seine Isolierung aus Cabucala madagascariensis | |
| EP0234019B1 (de) | Verwendung von wässrigen Auszügen von Epilobium angustifolium L. zu einer neuen medizinischen Indikation | |
| DE2240266C2 (de) | Verfahren zur Gewinnung von Lysergol und Canoclavindiacetat | |
| DE2201991C2 (de) | Verfahren zur Gewinnung von steroidalen Insektenhäutungshormonen | |
| DE2609533A1 (de) | Verfahren zur extraktion von wirkstoffen, insbesondere von heterosidestern, der kaffeesaeure, sowie diese verbindungen enthaltende arzneimittel | |
| DE2147263C3 (OSRAM) | ||
| DE2407294C2 (de) | Verfahren zur Gewinnung von 5,7,3',4'-Tetrahydroxy-flavan-3,4-diol und seinen Oligomeren | |
| DE2259388C3 (de) | Verfahren zur Gewinnung von Vincristin | |
| DE1145175B (de) | Verfahren zur Gewinnung von Rescidin aus Pflanzen der Rauwolfiaarten und zur Herstellung von dessen Salzen | |
| DE966726C (de) | Verfahren zur Anreicherung der Wirkstoffe von Rauwolfia-Arten | |
| DE2127921C3 (de) | Verfahren zur Isolierung der Nebenalkaloide von Vinca minor L. und Arzneimittel | |
| DE2260214C3 (de) | 3,4'7-Trihydroxyflavanon-3-di-Dhexuronsäuremethylester und Verfahren zu dessen Herstellung sowie diese Verbindung enthaltende Arzneimittel | |
| DD210277A5 (de) | Verfahren zur herstellung von physiologisch aktive pterocarpanverbindungen | |
| DE1099545B (de) | Verfahren zur Gewinnung von Alkaloiden der Raunescingruppe | |
| DE2243253A1 (de) | Verfahren zur gewinnung von zwei pharmakologisch wirksamen inhaltsstoffen aus anisocyclea-grandidieri | |
| DE1117593B (de) | Verfahren zur Gewinnung von Alkaloidgemischen aus Rauwolfiapflanzen |